Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Daiichi Sankyo
Baxter
Chubb
Colorcon
Boehringer Ingelheim
McKinsey
Healthtrust

Generated: November 19, 2018

DrugPatentWatch Database Preview

Hikma Farmaceutica Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?

HIKMA FARMACEUTICA has forty-five approved drugs.



Summary for Hikma Farmaceutica
US Patents:0
Tradenames:41
Ingredients:34
NDAs:45

Drugs and US Patents for Hikma Farmaceutica

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica PROGESTERONE progesterone INJECTABLE;INJECTION 091033-001 Oct 28, 2010 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 200300-001 Jan 26, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride INJECTABLE;INJECTION 077760-001 Jan 31, 2008 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065238-002 Mar 12, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica BUTORPHANOL TARTRATE butorphanol tartrate INJECTABLE;INJECTION 078247-001 Apr 29, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 202691-002 Feb 16, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 202691-001 Feb 16, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Covington
Baxter
Deloitte
Moodys
Daiichi Sankyo
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: